Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_provenance.
- NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_assertion description "[Several studies have demonstrated that polymorphisms in the LPIN1 and LPIN2 genes are associated with metabolic disease traits, including insulin sensitivity, diabetes, blood pressure and response to thiazolidinedione drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_provenance.
- NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_assertion evidence source_evidence_literature NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_provenance.
- NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_assertion SIO_000772 19369868 NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_provenance.
- NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_assertion wasDerivedFrom befree-20150227 NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_provenance.
- NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_assertion wasGeneratedBy ECO_0000203 NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP869661.RAD8dTJcuMxmx28D-z94kL6CsWZjZwXxd9du0-NESFhb4130_provenance.